Cargando…

What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?

BACKGROUND: The additional monitoring (AM)/black triangle concept is aimed to enhance ADR reporting for certain types of medicinal products for which the safety profile is less well established. PURPOSE: The objective of this survey was to assess (a) attitudes towards ADR reporting and reasons for n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Januskiene, Justina, Segec, Andrej, Slattery, Jim, Genov, Georgy, Plueschke, Kelly, Kurz, Xavier, Arlett, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894330/ https://www.ncbi.nlm.nih.gov/pubmed/33099846 http://dx.doi.org/10.1002/pds.5162

Ejemplares similares

Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data
por: Segec, Andrej, et al.
Publicado: (2020)

Improving the Safety of Medicines in the European Union: From Signals to Action
por: Potts, Joanne, et al.
Publicado: (2019)

Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources Database
por: Plueschke, Kelly, et al.
Publicado: (2022)

The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions
por: Candore, Gianmario, et al.
Publicado: (2021)

Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children
por: Candore, Gianmario, et al.
Publicado: (2020)

Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
por: Slattery, Jim, et al.
Publicado: (2020)

Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation
por: Pacurariu, Alexandra, et al.
Publicado: (2018)

An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance
por: Pinheiro, Luis C., et al.
Publicado: (2017)

Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works
por: Santoro, Aniello, et al.
Publicado: (2017)

Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
por: Jonker, Carla J., et al.
Publicado: (2022)

EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making
por: Plueschke, Kelly, et al.
Publicado: (2018)

Marketing Authorization Applications Made to the European Medicines Agency in 2018–2019: What was the Contribution of Real‐World Evidence?
por: Flynn, Robert, et al.
Publicado: (2021)

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection
por: Postigo, Rodrigo, et al.
Publicado: (2018)

Adverse reactions to the sulphite additives
por: Vally, Hassan, et al.
Publicado: (2012)

Adverse Reactions to Food Additives
por: Lessof, M. H.
Publicado: (1987)

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
por: Bakker, Elisabeth, et al.
Publicado: (2022)

Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019)

Understanding adverse drug reactions in package leaflets – an exploratory survey among health care professionals
por: Mühlbauer, Viktoria, et al.
Publicado: (2015)

Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations
por: Morales, Daniel R., et al.
Publicado: (2018)

Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population‐based nested case–control studies
por: Morales, Daniel R., et al.
Publicado: (2020)

International Collaboration in Real‐World Evidence Generation for Direct Acting Oral Anti‐Coagulants
por: Arlett, Peter, et al.
Publicado: (2020)

Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments
por: McGettigan, Patricia, et al.
Publicado: (2019)

Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance
por: Almandil, Noor B.
Publicado: (2016)

What are the psychological correlates of perceived adverse food reactions?
por: Mahmood, Saliha
Publicado: (2011)

Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
por: Maggo, Simran D. S., et al.
Publicado: (2015)

Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal
por: KC, Santosh, et al.
Publicado: (2013)

Spontaneous reporting of adverse drug reaction among health professionals in Ghana
por: Asiamah, Morrison, et al.
Publicado: (2022)

UK veterinary professionals’ perceptions and experiences of adverse drug reaction reporting
por: Davies, Heather, et al.
Publicado: (2022)

Erratum to: Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
por: Maggo, Simran D. S., et al.
Publicado: (2016)

Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study
por: Morales, Daniel R, et al.
Publicado: (2019)

Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study
por: Morales, Daniel R, et al.
Publicado: (2018)

Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice
por: Slattery, Jim, et al.
Publicado: (2022)

Adverse drug reaction classification by health professionals: appropriate discrimination between allergy and intolerance?
por: Shakib, Sepehr, et al.
Publicado: (2019)

368 Development of Interactome Network to Understand Adverse Drug Reactions for Antidepressant Medications
por: Patel, Beenish, et al.
Publicado: (2023)

System of adverse drug reactions reporting: What, where, how, and whom to report?
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2015)

1,4-Addition of TMSCCl(3) to Nitroalkenes: Efficient Reaction Conditions and Mechanistic Understanding
por: Wu, Na, et al.
Publicado: (2014)

Adverse reactions
Publicado: (1985)

Acetoacetate Based Thermosets Prepared by Dual-Michael Addition Reactions
por: Konuray, Osman, et al.
Publicado: (2019)

Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants
por: Kiguba, Ronald, et al.
Publicado: (2014)

Exploring Healthcare Professionals’ Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions
por: Srisuriyachanchai, Warisara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2smlqt5ee15300t0tq9k0kvp5t